Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Portland, Oregon 97239


The purpose of this study is to determine whether a training program in the use of ambulatory assistive devices (such as canes, walkers, etc) can reduce falls and increase functional mobility and neural connectivity in people with Multiple Sclerosis.

Study summary:

40 people with Multiple Sclerosis, who routinely use ambulatory assistive devices and have fallen at least once in the past year, will be randomized into two groups. One group will receive a 6-week training program in the use of their assistive device; the other group will be wait-listed, and may choose to receive the training after their participation in the study is completed. All participants will receive mobility assessments at baseline, 6-8 weeks later, and 3 months after that. All participants will record their falls on falls calendars. Participants in the training group will receive MRI scans to assess neural connectivity at baseline and after completion of the training program. The purpose of the study is to determine whether participation in the training program reduces falls and increases functional mobility when compared to the wait-listed group, and also to determine whether any change in neural connectivity, as assessed by MRI scans, is seen in those who participate in the training.


Inclusion Criteria: - Multiple Sclerosis of any type, - self-reported history of at least 1 fall in the previous year, - able to walk at least 25 feet with or without an assistive device, - clinically stable Multiple Sclerosis (no relapse in 30 days prior to enrollment), - intermittent or constant unilateral or bilateral assistance required to walk, - right-handed, willingness to remain consistent with medication use and level of physical activity for the duration of the study. Exclusion Criteria: - serious psychiatric or medical conditions that would preclude reliable participation in the study, - dementia (MMSE <24), - deafness, - blindness, - inability to follow directions in English, - significant upper extremity tremor or weakness, - more than 1 hour of assistive device training within the previous 3 years, - any exclusions to receiving MRI scans (implanted devices, anxiety, claustrophobia, body weight over 350 lbs).



Primary Contact:

Principal Investigator
Michelle H. Cameron, MD, PT MCR
Portland VA Medical Center

Backup Contact:


Location Contact:

Portland, Oregon 97239
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.